Prenatal Exposure to Lipopolysaccharide Alters Renal DNA Methyltransferase Expression in Rat Offspring

Jing Wang1, Jinghong Cui1, Rui Chen2

  • 1Department of Obstetrics and Gynecology, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.

Plos One
|January 20, 2017
PubMed

Insights

Prenatal inflammation exposure, via lipopolysaccharide (LPS), increases hypertension risk in adulthood by altering kidney DNA methyltransferases (DNMTs) through the IL-6/Fli-1 pathway and TNF-α.

Area of Science:

  • Developmental programming
  • Epigenetics
  • Cardiovascular research

Background:

  • Prenatal exposure to inflammation is linked to adult hypertension, but underlying mechanisms remain unclear.
  • Maternal inflammation, such as lipopolysaccharide (LPS) exposure, affects fetal cytokine levels (IL-6, TNF-α).
  • Interleukin-6 (IL-6) is known to regulate DNA methyltransferases (DNMTs) via the transcription factor Fli-1.

Purpose of the Study:

  • To investigate the role of intrarenal DNMTs in hypertension development following prenatal LPS exposure.
  • To explore the molecular pathways involved in epigenetic alterations in offspring kidneys.

Main Methods:

  • Pregnant rats were assigned to control, LPS, NF-κB inhibitor (PDTC), or LPS + PDTC groups.
  • Offspring gene expression (IL-6, TNF-α, Fli-1, DNMT1, DNMT3B) and global DNA methylation levels in the renal cortex were analyzed.
  • The impact of PDTC on LPS-induced changes was evaluated.

Main Results:

  • LPS offspring exhibited significantly increased IL-6, Fli-1, TNF-α, DNMT1, and DNMT3B expression.
  • Global DNA methylation in the renal cortex was markedly elevated in offspring from LPS-exposed mothers.
  • Prenatal administration of PDTC normalized these increases in gene expression and DNA methylation.

Conclusions:

  • Prenatal LPS exposure induces epigenetic changes in offspring kidneys, involving intrarenal DNMTs via the IL-6/Fli-1 and TNF-α pathways.
  • These epigenetic modifications are implicated in the development of hypertension in offspring exposed to maternal inflammation.
  • Inhibition of NF-κB signaling may offer a therapeutic strategy to prevent inflammation-induced developmental programming of hypertension.

Related Concept Videos